HK Stock MarketDetailed Quotes

01528 RS MACALLINE

Watchlist
  • 2.100
  • +0.080+3.96%
Market Closed Dec 2 16:08 CST
9.14BMarket Cap-2196P/E (TTM)

RS MACALLINE Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Turnover
-29.62%6.11B
-25.35%4.22B
-19.30%2.11B
-18.55%11.51B
-17.25%8.68B
-18.64%5.66B
-22.47%2.62B
-8.86%14.14B
-7.67%10.48B
-7.28%6.96B
Operating income
-29.62%6.11B
-25.35%4.22B
-19.30%2.11B
-18.55%11.51B
-17.25%8.68B
-18.64%5.66B
-22.47%2.62B
-8.86%14.14B
-7.67%10.48B
-7.28%6.96B
Cost of sales
----
29.94%-1.43B
----
15.34%-4.48B
----
12.15%-2.04B
----
1.09%-5.29B
----
---2.32B
Operating expenses
32.34%-2.48B
29.94%-1.43B
21.26%-833.76M
15.34%-4.48B
12.30%-3.66B
12.15%-2.04B
18.58%-1.06B
1.09%-5.29B
0.38%-4.17B
15.09%-2.32B
Gross profit
-27.65%3.63B
-22.77%2.8B
-17.97%1.28B
-20.48%7.03B
-20.52%5.01B
-21.89%3.62B
-24.90%1.56B
-12.95%8.84B
-11.93%6.31B
-2.80%4.64B
Selling expenses
32.71%-754.28M
23.60%-463.15M
21.57%-201.72M
4.64%-1.48B
-7.65%-1.12B
-1.23%-606.24M
7.49%-257.18M
24.63%-1.56B
24.07%-1.04B
27.74%-598.85M
Administrative expenses
28.78%-749.14M
22.68%-700.37M
17.49%-240.92M
5.33%-1.76B
-7.80%-1.05B
-8.92%-905.79M
17.44%-291.98M
25.21%-1.86B
27.94%-975.73M
5.72%-831.59M
Research and development expenses
18.80%-11.18M
21.65%-7.34M
26.41%-3.66M
57.63%-19.63M
59.98%-13.77M
63.30%-9.37M
63.53%-4.97M
---46.33M
18.30%-34.41M
5.25%-25.52M
Profit from asset sales
1,051.98%74.28M
----
95.43%-21.31K
----
2,229.29%6.45M
----
-104.38%-466.76K
----
-102.18%-302.84K
----
Revaluation surplus
-189.58%-1.21B
-297.48%-1.18B
-2,991.36%-324.39M
-113.00%-1.55B
-517.62%-416.53M
-30.83%-296.25M
-112.50%-10.49M
-194.19%-725.83M
-58.32%99.74M
-199.74%-226.43M
-Changes in the fair value of other assets
-189.58%-1.21B
-297.48%-1.18B
-2,991.36%-324.39M
-113.00%-1.55B
-517.62%-416.53M
-30.83%-296.25M
-112.50%-10.49M
---725.83M
-58.32%99.74M
-199.74%-226.43M
Impairment and provision
-2.52%-759.82M
-88.22%-474.77M
-53.62%-69.7M
-238.41%-1.3B
-253.57%-741.12M
-48.85%-252.25M
-26.97%-45.37M
48.83%-385.21M
-22.03%-209.61M
-6.30%-169.47M
-Other impairment is provision
-2.52%-759.82M
-88.22%-474.77M
-53.62%-69.7M
-238.41%-1.3B
-253.57%-741.12M
-48.85%-252.25M
-26.97%-45.37M
27.76%-385.21M
-22.03%-209.61M
-6.30%-169.47M
Special items of operating profit
-68.52%45.63M
-83.17%-174.05M
-228.65%-7.89M
-516.97%-881.04M
-30.45%144.95M
-162.70%-95.02M
-90.87%6.13M
-119.69%-142.8M
-65.04%208.41M
-71.68%151.54M
Operating profit
-101.52%-22.94M
-113.71%-199.83M
-60.55%339.89M
-99.10%37.32M
-62.61%1.51B
-50.38%1.46B
-40.90%861.65M
-22.61%4.13B
-14.97%4.05B
-14.70%2.94B
Financing cost
2.64%-1.83B
-3.37%-1.3B
-22.37%-644.51M
-6.04%-2.65B
-6.06%-1.88B
-0.51%-1.26B
7.71%-526.68M
7.10%-2.5B
6.14%-1.77B
-2.63%-1.25B
Share of profits of associates
----
-97.84%1.52M
----
6,227.03%65.3M
----
1,217.68%70.19M
----
-9.95%1.03M
----
--5.33M
Share of profit from joint venture company
----
-302.91%-37.69M
----
145.18%12.41M
----
-40.51%18.57M
----
-162.35%-27.47M
----
--31.22M
Special items of earning before tax
-22.82%-202.97M
----
-65.40%-54.4M
----
-2,775.61%-165.27M
----
-476.94%-32.89M
----
184.23%6.18M
----
Earning before tax
-286.88%-2.05B
-633.12%-1.54B
-218.85%-359.02M
-258.96%-2.54B
-123.29%-531.18M
-83.26%288.2M
-65.74%302.08M
-40.48%1.6B
-20.36%2.28B
-22.53%1.72B
Tax
155.38%50.27M
164.77%113.19M
101.64%1.56M
96.05%-30.81M
90.51%-90.77M
77.07%-174.75M
61.62%-95.6M
-33.80%-780.77M
-34.23%-956.69M
-31.93%-762.18M
After-tax profit from continuing operations
-222.33%-2B
-1,354.53%-1.42B
-273.12%-357.45M
-414.66%-2.57B
-146.98%-621.94M
-88.18%113.45M
-67.35%206.47M
-61.11%816.88M
-38.45%1.32B
-41.65%959.75M
Earning after tax
-222.33%-2B
-1,354.53%-1.42B
-273.12%-357.45M
-414.66%-2.57B
-146.98%-621.94M
-88.18%113.45M
-67.35%206.47M
-61.11%816.88M
-38.45%1.32B
-41.65%959.75M
Minority profit
-56.48%-117.89M
-486.44%-86.48M
-64.19%14.06M
-214.02%-157.71M
-1,359.26%-75.34M
33.94%-14.75M
159.95%39.25M
0.90%138.32M
-93.05%5.98M
-116.50%-22.32M
Profit attributable to shareholders
-245.19%-1.89B
-1,142.76%-1.34B
-322.16%-371.51M
-455.56%-2.41B
-141.47%-546.6M
-86.95%128.2M
-76.04%167.22M
-65.44%678.57M
-36.17%1.32B
-34.95%982.07M
Basic earnings per share
-230.77%-0.43
-1,133.33%-0.31
-325.00%-0.09
-443.75%-0.55
-143.33%-0.13
-86.96%0.03
-75.00%0.04
-67.35%0.16
-43.40%0.3
-41.03%0.23
Diluted earnings per share
-1,133.33%-0.31
-443.75%-0.55
-86.96%0.03
-67.35%0.16
0.23
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
CAS (2007)
IAS
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
Rong Shing Certified Public Accountants (Special General Partnership), Advanced Opportunity Accountants Limited
--
--
--
National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Turnover -29.62%6.11B-25.35%4.22B-19.30%2.11B-18.55%11.51B-17.25%8.68B-18.64%5.66B-22.47%2.62B-8.86%14.14B-7.67%10.48B-7.28%6.96B
Operating income -29.62%6.11B-25.35%4.22B-19.30%2.11B-18.55%11.51B-17.25%8.68B-18.64%5.66B-22.47%2.62B-8.86%14.14B-7.67%10.48B-7.28%6.96B
Cost of sales ----29.94%-1.43B----15.34%-4.48B----12.15%-2.04B----1.09%-5.29B-------2.32B
Operating expenses 32.34%-2.48B29.94%-1.43B21.26%-833.76M15.34%-4.48B12.30%-3.66B12.15%-2.04B18.58%-1.06B1.09%-5.29B0.38%-4.17B15.09%-2.32B
Gross profit -27.65%3.63B-22.77%2.8B-17.97%1.28B-20.48%7.03B-20.52%5.01B-21.89%3.62B-24.90%1.56B-12.95%8.84B-11.93%6.31B-2.80%4.64B
Selling expenses 32.71%-754.28M23.60%-463.15M21.57%-201.72M4.64%-1.48B-7.65%-1.12B-1.23%-606.24M7.49%-257.18M24.63%-1.56B24.07%-1.04B27.74%-598.85M
Administrative expenses 28.78%-749.14M22.68%-700.37M17.49%-240.92M5.33%-1.76B-7.80%-1.05B-8.92%-905.79M17.44%-291.98M25.21%-1.86B27.94%-975.73M5.72%-831.59M
Research and development expenses 18.80%-11.18M21.65%-7.34M26.41%-3.66M57.63%-19.63M59.98%-13.77M63.30%-9.37M63.53%-4.97M---46.33M18.30%-34.41M5.25%-25.52M
Profit from asset sales 1,051.98%74.28M----95.43%-21.31K----2,229.29%6.45M-----104.38%-466.76K-----102.18%-302.84K----
Revaluation surplus -189.58%-1.21B-297.48%-1.18B-2,991.36%-324.39M-113.00%-1.55B-517.62%-416.53M-30.83%-296.25M-112.50%-10.49M-194.19%-725.83M-58.32%99.74M-199.74%-226.43M
-Changes in the fair value of other assets -189.58%-1.21B-297.48%-1.18B-2,991.36%-324.39M-113.00%-1.55B-517.62%-416.53M-30.83%-296.25M-112.50%-10.49M---725.83M-58.32%99.74M-199.74%-226.43M
Impairment and provision -2.52%-759.82M-88.22%-474.77M-53.62%-69.7M-238.41%-1.3B-253.57%-741.12M-48.85%-252.25M-26.97%-45.37M48.83%-385.21M-22.03%-209.61M-6.30%-169.47M
-Other impairment is provision -2.52%-759.82M-88.22%-474.77M-53.62%-69.7M-238.41%-1.3B-253.57%-741.12M-48.85%-252.25M-26.97%-45.37M27.76%-385.21M-22.03%-209.61M-6.30%-169.47M
Special items of operating profit -68.52%45.63M-83.17%-174.05M-228.65%-7.89M-516.97%-881.04M-30.45%144.95M-162.70%-95.02M-90.87%6.13M-119.69%-142.8M-65.04%208.41M-71.68%151.54M
Operating profit -101.52%-22.94M-113.71%-199.83M-60.55%339.89M-99.10%37.32M-62.61%1.51B-50.38%1.46B-40.90%861.65M-22.61%4.13B-14.97%4.05B-14.70%2.94B
Financing cost 2.64%-1.83B-3.37%-1.3B-22.37%-644.51M-6.04%-2.65B-6.06%-1.88B-0.51%-1.26B7.71%-526.68M7.10%-2.5B6.14%-1.77B-2.63%-1.25B
Share of profits of associates -----97.84%1.52M----6,227.03%65.3M----1,217.68%70.19M-----9.95%1.03M------5.33M
Share of profit from joint venture company -----302.91%-37.69M----145.18%12.41M-----40.51%18.57M-----162.35%-27.47M------31.22M
Special items of earning before tax -22.82%-202.97M-----65.40%-54.4M-----2,775.61%-165.27M-----476.94%-32.89M----184.23%6.18M----
Earning before tax -286.88%-2.05B-633.12%-1.54B-218.85%-359.02M-258.96%-2.54B-123.29%-531.18M-83.26%288.2M-65.74%302.08M-40.48%1.6B-20.36%2.28B-22.53%1.72B
Tax 155.38%50.27M164.77%113.19M101.64%1.56M96.05%-30.81M90.51%-90.77M77.07%-174.75M61.62%-95.6M-33.80%-780.77M-34.23%-956.69M-31.93%-762.18M
After-tax profit from continuing operations -222.33%-2B-1,354.53%-1.42B-273.12%-357.45M-414.66%-2.57B-146.98%-621.94M-88.18%113.45M-67.35%206.47M-61.11%816.88M-38.45%1.32B-41.65%959.75M
Earning after tax -222.33%-2B-1,354.53%-1.42B-273.12%-357.45M-414.66%-2.57B-146.98%-621.94M-88.18%113.45M-67.35%206.47M-61.11%816.88M-38.45%1.32B-41.65%959.75M
Minority profit -56.48%-117.89M-486.44%-86.48M-64.19%14.06M-214.02%-157.71M-1,359.26%-75.34M33.94%-14.75M159.95%39.25M0.90%138.32M-93.05%5.98M-116.50%-22.32M
Profit attributable to shareholders -245.19%-1.89B-1,142.76%-1.34B-322.16%-371.51M-455.56%-2.41B-141.47%-546.6M-86.95%128.2M-76.04%167.22M-65.44%678.57M-36.17%1.32B-34.95%982.07M
Basic earnings per share -230.77%-0.43-1,133.33%-0.31-325.00%-0.09-443.75%-0.55-143.33%-0.13-86.96%0.03-75.00%0.04-67.35%0.16-43.40%0.3-41.03%0.23
Diluted earnings per share -1,133.33%-0.31-443.75%-0.55-86.96%0.03-67.35%0.160.23
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IASCAS (2007)IAS
Audit Opinions ------Unqualified Opinion------Unqualified Opinion----
Auditor ------Rong Shing Certified Public Accountants (Special General Partnership), Advanced Opportunity Accountants Limited------National Health Certified Public Accountants Limited, ZTE Caiguanghua Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data